"Malaysia Pharmaceuticals & Healthcare Report Q3 2014" Now Available at Fast Market Research
We remain generally optimistic towards Malaysia's commitment to provide better quality and access to healthcare , as the government plans to expand and upgrade its hospital network. However, we have downgraded Malaysia's pharmaceutical sales forecast due to a slowdown in pharmaceutical trade in 2013. The country's slower economic growth in 2014, coupled with the fact that investment in the pharmaceuticals sector will take longer than expected to bring returns, are downside risks to our outlook.
View full press release